Skip to content
Cefixime
Suprax (cefixime) is a small molecule pharmaceutical. Cefixime was first approved as Suprax on 1989-04-28. It is used to treat bacterial infections, bacterial pneumonia, bacterial skin diseases, bronchitis, and escherichia coli infections amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Suprax (generic drugs available since 2007-04-10)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cefixime
Tradename
Company
Number
Date
Products
SUPRAXLupin ResearchN-202091 RX2013-02-20
1 products, RLD, RS
SUPRAXLupin ResearchN-203195 RX2012-06-01
1 products, RLD, RS
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cefiximeANDA2023-03-13
supraxANDA2023-01-10
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infectionsD001424A49
bacterial pneumoniaEFO_1001272D018410J15.9
bacterial skin diseasesD017192
bronchitisD001991J40
escherichia coli infectionsEFO_1001318D004927B96.20
gonorrheaDOID_7551D006069A54
haemophilus infectionsEFO_1001127D006192
klebsiella infectionsEFO_1001353D007710
moraxellaceae infectionsEFO_1001072D045828
otitis mediaEFO_0004992D010033H66.9
Show 5 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Cefixime, Suprax, Lupin Ltd
92331122028-12-14DPU-1676
ATC Codes
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01D: Other beta-lactam antibacterials in atc
J01DD: Third-generation cephalosporins
J01DD08: Cefixime
J01R: Combinations of antibacterials
J01RA: Combinations of antibacterials
J01RA15: Cefixime and ornidazole
HCPCS
No data
Clinical
Clinical Trials
47 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Febrile neutropeniaD0641472136
PneumoniaD011014EFO_0003106J18213
SepsisD018805A41.9112
BacteremiaD016470EFO_0003033R78.81112
LeukemiaD007938C95112
PeritonitisD010538EFO_0008588K65112
Cystic fibrosisD003550EFO_0000390E8411
Aspiration pneumoniaD011015EFO_1001399J69.011
EndocarditisD004696EFO_0000465I3311
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary tract infectionsD014552EFO_0003103N39.0268
NeutropeniaD009503D70123
Septic shockD012772A48.3112
NeoplasmsD009369C80112
PyelonephritisD011704EFO_1001141N10-N1622
InfectionsD007239EFO_000054411
LymphomaD008223C85.911
Hot flashesD01958411
Wound infectionD014946111
Ventilator-associated pneumoniaD053717EFO_1001865J95.85111
Show 7 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastrointestinal microbiomeD00006919611
Communicable diseasesD00314111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients55
Bacterial infectionsD001424A4922
PharmacokineticsD01059922
Renal insufficiencyD051437HP_0000083N1911
Myelodysplastic syndromesD009190D4611
Myeloid leukemia acuteD015470C92.011
Breast neoplasmsD001943EFO_0003869C5011
Non-hodgkin lymphomaD008228C85.911
Primary myelofibrosisD055728D47.411
Multiple myelomaD009101C90.011
Show 18 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD01663811
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCEFIXIME
INNcefixime
Description
Cefixime is a third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections. It has a role as an antibacterial drug and a drug allergen.
Classification
Small molecule
Drug classcephalosporins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1
Identifiers
PDB
CAS-ID79350-37-1
RxCUI1546021
ChEMBL IDCHEMBL1541
ChEBI ID472657
PubChem CID5362065
DrugBankDB00671
UNII IDXZ7BG04GJX (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 5,796 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
4,703 adverse events reported
View more details